Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer.

Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer.

OBJECTIVE: The aim of this study was to determine the optimal patient-reported outcome measure (PROM) for assessing symptom benefit in trials of palliative chemotherapy for women with symptomatic ovarian cancer. METHODS: Candidate PROMs were EORTC QLQ-C30 plus ovarian-specific QLQ-OV28, Functional A...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: King, M, Stockler, MR, Butow, P, O'Connell, R, Voysey, M, Oza, A, Gillies, K, Donovan, H, Mercieca-Bebber, R, Martyn, J, Sjoquist, K, Friedlander, M
التنسيق: Journal article
اللغة:English
منشور في: Lippincott Williams and Wilkins 2014

مواد مشابهة

مواد مشابهة